Early Access
Phase One
Limited to the first 250 clinicians — no subscription, preferred Phase Two benefits.
250 spots
Limited release
Your entry point
- ✓Reduce surface touching & cross-contamination
- ✓Voice EHR & hands-free documentation
- ✓Preferred benefits for Phase Two
- ✓No subscription for Phase One
Register at Contact@veevia.ai